Author Question: When adjusting the sensitivity control on an intermittent positive-pressure breathing device, which ... (Read 28 times)

Caiter2013

  • Hero Member
  • *****
  • Posts: 607
When adjusting the sensitivity control on an intermittent positive-pressure breathing device, which of the following parameters are you changing?
 
  a. Volume of gas delivered to the patient during inhalation
  b. Effort required to cycle the device off (end inspiration)
  c. Effort required to cycle the device on (begin inspiration)
  d. Maximum pressure delivered to the patient during inhalation

Question 2

Which of the following are appropriate initial settings for intermittent positive-pressure breathing given to a new patient?
 
  a. Sensitivity 2 cm H2O; pressure 20 to 25 cm H2O; high flow
  b. Sensitivity 3 to 4 cm H2O; pressure 5 to 10 cm H2O; moderate flow
  c. Sensitivity 1 to 2 cm H2O; pressure 10 to 15 cm H2O; moderate flow
  d. Sensitivity 8 cm H2O; pressure 15 cm H2O; moderate flow



dpost18

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

ANS: C
The machine should be set so that a breath can be initiated with minimal patient effort.

Answer to Question 2

ANS: C
A sensitivity or trigger level of 1 to 2 cm H2O is adequate for most patients. Initially, system pressure is set to between 10 and 15 cm H2O.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

For a complete list of videos, visit our video library